Search - tctmd.com

Displaying 501 - 520 of 528

Sort: Relevancy | Date

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Early Morning Circadian Rhythms Linked to Stent Thrombosis

February 21, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

Advertisement

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Poor Association Between Stent Thrombosis, Platelet Function Tests

Apixaban Increases Major Bleeding in High-Risk ACS Patients

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Ticagrelor Gains FDA Approval for Use in ACS

After GRAVITAS: Is There a Future for Functional Platelet Testing?

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Early Morning Circadian Rhythms Linked to Stent Thrombosis

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content